It was found that the mRNA levels of MARCH5 were significantly increased in breast cancer, and the overall survival rate of breast cancer patients with high levels of MARCH5 expression was lower (Figure 3C,D). This evidence concerns the gene MARCHF5 and breast carcinoma.